Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored ...

Winter brings with it a higher risk of infectious diseases. Here are the common viral outbreaks seen in the United States and ...

Symptoms of respiratory syncytial virus, or RSV, may start off similar to a common cold, with sneezing and a runny nose. But ...

A briefing document from the Food and Drug Administration (FDA) says that enrollment for all clinical studies of vaccines for ...

In a new study, the RSV drug nirsevimab was 93% effective at preventing young children from being hospitalized for the ...

The FDA flagged at least five cases of severe or very severe RSV lower respiratory tract infections in infants immunized with ...

Fiona P. Havers, MD, MHS, spoke with Physician’s Weekly about managing RSV as a newly vaccine-preventable disease now that ...

Physicians in PA don’t expect to see the surges they saw during the first winters of the COVID-19 pandemic, but encouraged ...

While RSV is not on the CDC’s current list of Nationally Notifiable Diseases like COVID and influenza, a new rule from the ...

You may think you can avoid getting sick, but in Georgia, respiratory virus season is already upon us. Even if you lead an ...

Research led by the CDC and conducted at seven academic pediatric medical centers in the United States finds nirsevimab (sold ...

COVID-19, influenza, and RSV vaccination coverage is low among nursing home residents early in the 2024 to 2025 season.